Fortress Biotech, Inc. (FBIOP)

18.61USD +0.27% (+0.05)

Over 1M: -1.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

18 19 20
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -21.7M Q3 '21 — Free Cash Flow: -22.2M Q4 '21 — Operating Cash Flow: -38.7M Q4 '21 — Free Cash Flow: -40.7M Q1 '22 — Operating Cash Flow: -46.9M Q1 '22 — Free Cash Flow: -48.2M Q2 '22 — Operating Cash Flow: -41.4M Q2 '22 — Free Cash Flow: -41.7M Q3 '22 — Operating Cash Flow: -43.3M Q3 '22 — Free Cash Flow: -44.3M Q4 '22 — Operating Cash Flow: -47.8M Q4 '22 — Free Cash Flow: -47.9M Q1 '23 — Operating Cash Flow: -43.2M Q1 '23 — Free Cash Flow: -43.2M Q2 '23 — Operating Cash Flow: -33.3M Q2 '23 — Free Cash Flow: -33.3M Q3 '23 — Operating Cash Flow: -16.8M Q3 '23 — Free Cash Flow: -16.8M Q4 '23 — Operating Cash Flow: -34.9M Q4 '23 — Free Cash Flow: -35M Q1 '24 — Operating Cash Flow: -25.4M Q2 '24 — Operating Cash Flow: -21.8M Q3 '24 — Operating Cash Flow: -20.1M Q3 '24 — Free Cash Flow: -20.1M Q4 '24 — Operating Cash Flow: -12.9M Q4 '24 — Free Cash Flow: -12.9M Q1 '25 — Operating Cash Flow: -19.6M Q2 '25 — Operating Cash Flow: -27.6M Q3 '25 — Operating Cash Flow: -6.1M Q4 '25 — Operating Cash Flow: -12.5M Q1 '26 — Operating Cash Flow: 203.9M Q2 '26 — Operating Cash Flow: -59.3M 0 60M 120M 180M 240M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Cash Flow Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-12-31, -122 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.8
OE margin 168.9%
SBC / sales 15.0%
Oper. margin -42.9%
ROIC -904.2%
Accruals -4.5%
FCF margin 183.9%
OCF margin 183.9%
Profit margin 163.3%
ROA 35.3%
ROE 68.1%
Gross margin 65.6%
EBITDA margin -42.3%
ROCE -11.5%
Capex / sales —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

8.3
EV/OE 4.0×
EV/Sales 6.7×
FCF yield 20.3%
P/C 3.2×
P/E 5.5×
P/B 3.8×
Div. yield 0.08%
EV/EBIT —
EV/GP —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 0.35
Cash / Debt 5.6×
Debt payback 0.0 yr
Payout 0.45%
Quick ratio 3.8×
Debt / Eq 0.21×
F-score 5.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales/sh Y/Y -14.0%
Sales Q/Q +14.0%
Div. growth -4.3%
Shares change +34.3%
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.